Serum and Tissue Profiling in Bladder Cancer Combining Protein and Tissue Arrays
- 2 November 2009
- journal article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 9 (1), 164-173
- https://doi.org/10.1021/pr900273u
Abstract
Aiming at identifying biomarkers for bladder cancer, the serum proteome was explored in a pilot study through a profiling approach using protein arrays. Supervised analyses identified a panel 171 immunogenic proteins differentially expressed between patients with bladder cancer (n = 12) and controls without the disease (n = 10). The microanatomical expression patterns of novel immunogenic proteins, especially dynamin and clusterin, were found significantly associated with histopathologic variables and overall survival, as confirmed by immunohistochemistry using an independent series of bladder tumors contained in tissue microarrays (n = 289). Thus, the protein arrays approach has identified a panel of immunogenic candidates that may potentially play a role as diagnostic biomarkers, especially for muscle invasive disease. Moreover, the protein expression patterns of dynamin and clusterin in bladder tumors were shown to adjunct for histopathologic staging and clinical outcome prognosis.Keywords
This publication has 46 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Molecular Alterations Associated With Bladder Cancer ProgressionSeminars in Oncology, 2007
- Bladder cancer: Epidemiology, staging and grading, and diagnosisUrology, 2005
- Serum Proteomic Fingerprinting Discriminates Between Clinical Stages and Predicts Disease Progression in Melanoma PatientsJournal of Clinical Oncology, 2005
- Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosisCancer Detection Prevention, 2004
- Analysis of the humoral immune response to immunoselected phage‐displayed peptides by a microarray‐based methodProteomics, 2004
- An Autoantibody-Mediated Immune Response to Calreticulin Isoforms in Pancreatic CancerCancer Research, 2004
- Humoral Immune Response to -Methylacyl-CoA Racemase and Prostate CancerJNCI Journal of the National Cancer Institute, 2004
- Development of Natural Protein Microarrays for Diagnosing Cancer Based on an Antibody Response to Tumor AntigensJournal of Proteome Research, 2004
- Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivityProteomics, 2003